Neo Ivy Capital Management Agios Pharmaceuticals, Inc. Transaction History

Neo Ivy Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$29.58 - $49.78 $82,232 - $138,388	-2,780 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$41.92 - $58.18 $116,537 - $161,740	2,780 New	2,780 $149,000
Q2 2020 Aug 17, 2020	SELL	$34.45 - $53.48 $95,771 - $148,674	-2,780 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$34.45 - $53.48 $95,771 - $148,674	2,780 New	2,780 $149,000

233

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.95B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.